David Featherstone

TL;DR: The lesson learned from nearly 20 years of virologic surveillance for measles is described, the global databases for measles sequences are described, and regional updates about measles genotypes detected by recent surveillance activities are provided.

TL;DR: The introduction of rubella vaccine is cost-effective and cost-beneficial but requires ongoing strengthening of routine immunization services and surveillance systems.

TL;DR: Molecular characterization of measles viruses has provided a valuable tool for measuring the effectiveness of measles control programs, and virologic surveillance needs to be expanded in all areas of the world and conducted during all phases of measlescontrol.

TL;DR: A standardized nomenclature and an analysis protocol for the genetic characterisation of mumps strains to facilitate expansion of molecular epidemiological studies are proposed.

TL;DR: The panel concluded that measles can and should be eradicated and that global eradication by 2020 is feasible given evidence of measurable progress towards the 2015 targets, and that measles eradication activities should be carried out in the context of strengthening.